Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 08, 2018 06:30 ET | Source: Emergent Biosolutions, Inc.

Emergent BioSolutions to Release Fourth Quarter and Full Year 2017 Financial Results and Conduct a Conference Call on February 22, 2018

GAITHERSBURG, Md., Feb. 08, 2018 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) will host a conference call on Thursday, February 22, 2018 at 5:00 pm (Eastern Time) to discuss the...
January 08, 2018 06:30 ET | Source: Emergent Biosolutions, Inc.

Emergent BioSolutions Announces Preliminary 2017 Financial Results and Provides 2018 Financial Outlook

GAITHERSBURG, Md., Jan. 08, 2018 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) today announced preliminary unaudited 2017 financial results and guidance for 2018. Daniel J. Abdun-Nabi,...
January 04, 2018 07:00 ET | Source: Emergent Biosolutions, Inc.

Emergent BioSolutions Initiates Phase 2 Clinical Study to Evaluate FLU-IGIV to Treat Serious Influenza A Infection

GAITHERSBURG, Md., Jan. 04, 2018 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) today announced the initiation of a Phase 2 dose ranging study to evaluate the safety, pharmacokinetics,...
January 03, 2018 07:00 ET | Source: Emergent Biosolutions, Inc.

Emergent BioSolutions to Participate in First Quarter 2018 Investor Conferences

GAITHERSBURG, Md., Jan. 03, 2018 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) announced today that a member of the company’s senior management team will participate in the following...
December 12, 2017 07:00 ET | Source: Emergent Biosolutions, Inc.

Emergent BioSolutions Awarded Department of National Defence Contract to Supply Anthrasil to the Canadian Government

GAITHERSBURG, Md., Dec. 12, 2017 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) today announced that it has been awarded a contract by the Department of National Defence (DND) valued at...
November 30, 2017 07:00 ET | Source: Emergent Biosolutions, Inc.

Emergent BioSolutions to Host 2017 Analyst & Investor Day

GAITHERSBURG, Md., Nov. 30, 2017 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) today announced that the company will host an analyst and investor day on December 7, 2017 in New York...
November 20, 2017 07:00 ET | Source: Emergent Biosolutions, Inc.

Emergent BioSolutions Receives FDA Approval to Manufacture ACAM2000 at Canton, Massachusetts Facility

GAITHERSBURG, Md., Nov. 20, 2017 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) today announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics...
November 14, 2017 17:38 ET | Source: Emergent Biosolutions, Inc.

Emergent BioSolutions Announces Notice of Termination of Conversion Rights of 2.875% Convertible Senior Notes Due 2021

GAITHERSBURG, Md., Nov. 14, 2017 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) announced today that it has issued a Notice of Termination of Conversion Rights for all of its outstanding...
November 02, 2017 16:15 ET | Source: Emergent Biosolutions, Inc.

Emergent BioSolutions Reports Third Quarter and Nine Months 2017 Financial Results; Raises Calendar Year 2017 Guidance

GAITHERSBURG, Md., Nov. 02, 2017 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) reported financial results for the quarter and nine months ended September 30, 2017. FINANCIAL HIGHLIGHTS ...
October 19, 2017 07:00 ET | Source: Emergent Biosolutions, Inc.

Emergent BioSolutions to Release Third Quarter and Nine Months 2017 Financial Results and Conduct a Conference Call on November 2, 2017

GAITHERSBURG, Md., Oct. 19, 2017 (GLOBE NEWSWIRE) -- Emergent BioSolutions (NYSE:EBS) will release its financial results for the third quarter and nine months of 2017 immediately after market close...